01/13/2012 - 12:13pm

Bristol-Myers Squibb has officially launched its tender offer for Inhibitex, the drug maker said Friday.

01/12/2012 - 12:27pm

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

01/11/2012 - 2:47pm

Fleming Pharmaceuticals has sold rights of several of its products to Valeant International, Fleming said Wednesday.

01/10/2012 - 10:56am

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

01/09/2012 - 4:21pm

Diplomat Specialty Pharmacy has received limited distribution rights for a neovascular age-related macular degeneration treatment.

01/09/2012 - 1:21pm

Endo Pharmaceuticals announced a short-term supply constraint of analgesic products, including Opana ER, due to the temporary shutdown of a manufacturing facility operated by Novartis Consumer Health.

01/09/2012 - 10:52am

Bristol-Myers Squibb is buying Inhibitex for $2.5 billion, the companies said.

01/06/2012 - 1:42pm

Sandoz has launched a shampoo used to treat severe scalp psoriasis, the generic drug maker said.

01/06/2012 - 11:10am

The Food and Drug Administration has granted fast-track designation to a drug currently under development by Achillion Pharmaceuticals for hepatitis C, the company said.